Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation

Technology appraisal guidance
Reference number: TA275
Published: 27 February 2013
Last updated: 02 July 2021

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: NICE clarification letter to the manufacturer

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: NICE clarification letter to the manufacturer

Stroke and systemic embolism (prevention, non-valvular atrial fibrillation) - apixaban: NICE clarification letter to the manufacturer
23 January 2013
(239 Kb 9 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 21 January 2013